SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-003242
Filing Date
2017-03-31
Accepted
2017-03-31 16:51:01
Documents
83
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1751297
2 ex-21.htm EX-21 6407
3 ex23-1.htm EX-23.1 5076
4 ex31-1.htm EX-31.1 22089
5 ex31-2.htm EX-31.2 22369
6 ex32-1.htm EX-32.1 8711
7 ex32-2.htm EX-32.2 8740
8 image_002.jpg GRAPHIC 19839
  Complete submission text file 0001493152-17-003242.txt   6947915

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE heb-20161231.xml EX-101.INS 1401407
10 XBRL SCHEMA FILE heb-20161231.xsd EX-101.SCH 65380
11 XBRL CALCULATION FILE heb-20161231_cal.xml EX-101.CAL 58982
12 XBRL DEFINITION FILE heb-20161231_def.xml EX-101.DEF 264118
13 XBRL LABEL FILE heb-20161231_lab.xml EX-101.LAB 459547
14 XBRL PRESENTATION FILE heb-20161231_pre.xml EX-101.PRE 357703
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27072 | Film No.: 17731035
SIC: 2836 Biological Products, (No Diagnostic Substances)